|
|
| (5 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #redirect: [[Acebutolol#Adverse Reactions]] |
| {{Acebutolol}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Adverse Reactions==
| |
| Sectral is well tolerated in properly selected patients. Most adverse reactions have been mild, not required discontinuation of therapy, and tended to decrease as duration of treatment increases.
| |
| | |
| The following table shows the frequency of treatment-related side effects derived from controlled clinical trials in patients with hypertension, angina pectoris, and arrhythmia. These patients received Sectral, propranolol, or hydrochlorothiazide as monotherapy, or placebo.
| |
| {|
| |
| |-
| |
| |[[File:Acebutolol01.jpg|thumb|800px]]
| |
| |-
| |
| |}
| |
| The following selected (potentially important) side effects were seen in up to 2% of Sectral patients:
| |
| | |
| '''Cardiovascular''': [[hypotension]], [[bradycardia]], [[heart failure]].
| |
| | |
| '''Central Nervous System''': [[anxiety]], hyper/[[hypoesthesia]], [[impotence]].
| |
| | |
| '''Dermatological''': [[pruritus]].
| |
| | |
| '''Gastrointestinal''': [[vomiting]], [[abdominal pain]].
| |
| | |
| '''Genitourinary''': [[dysuria]], [[nocturia]].
| |
| | |
| '''Liver and Biliary System''': A small number of cases of liver abnormalities (increased SGOT, SGPT, LDH) have been reported in association with acebutolol therapy. In some cases increased bilirubin or alkaline phosphatase, fever, [[malaise]], [[dark urine]], [[anorexia]], [[nausea]], [[headache]], and/or other symptoms have been reported. In some of the reported cases, the symptoms and signs were confirmed by rechallenge with acebutolol. The abnormalities were reversible upon cessation of acebutolol therapy.
| |
| | |
| '''Musculoskeletal''': [[back pain]], [[joint pain]].
| |
| | |
| '''Respiratory''': [[pharyngitis]], [[wheezing]].
| |
| | |
| '''Special Senses''': [[conjunctivitis]], dry eye, eye pain.
| |
| | |
| '''Autoimmune''': In extremely rare instances, [[systemic lupus erythematosus]] has been reported.
| |
| | |
| The incidence of drug-related adverse effects (volunteered and solicited) according to Sectral dose is shown below. (Data from 266 [[hypertensive]] patients treated for 3 months on a constant dose.)
| |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SECTRAL (ACEBUTOLOL HYDROCHLORIDE) CAPSULE [PROMIUS PHARMA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7eee95bf-0452-4d6e-9712-33403768695a | publisher = | date = | accessdate = 3 February 2014 }}</ref>
| |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |